A detailed history of Gries Financial LLC transactions in Amgen Inc stock. As of the latest transaction made, Gries Financial LLC holds 10,338 shares of AMGN stock, worth $3.3 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
10,338
Previous 10,623 2.68%
Holding current value
$3.3 Million
Previous $3.02 Million 6.95%
% of portfolio
0.75%
Previous 0.56%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$262.75 - $319.31 $74,883 - $91,003
-285 Reduced 2.68%
10,338 $3.23 Million
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $33,877 - $40,894
-126 Reduced 1.17%
10,623 $3.02 Million
Q4 2023

Feb 13, 2024

BUY
$255.7 - $288.46 $44,491 - $50,192
174 Added 1.65%
10,749 $3.1 Million
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $38,482 - $47,776
-176 Reduced 1.64%
10,575 $2.84 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $15,427 - $18,242
72 Added 0.67%
10,751 $2.39 Million
Q1 2023

Jun 21, 2023

SELL
$225.79 - $275.2 $243,401 - $296,665
-1,078 Reduced 9.17%
10,679 $2.58 Million
Q4 2022

Jan 10, 2023

BUY
$229.03 - $291.01 $770,685 - $979,248
3,365 Added 40.1%
11,757 $3.09 Million
Q3 2022

Oct 31, 2022

BUY
$224.46 - $253.15 $62,848 - $70,882
280 Added 3.45%
8,392 $1.89 Million
Q2 2022

Aug 16, 2022

SELL
$230.71 - $256.74 $736,426 - $819,514
-3,192 Reduced 28.24%
8,112 $1.97 Million
Q1 2022

Apr 29, 2022

BUY
$219.27 - $242.57 $760,428 - $841,232
3,468 Added 44.26%
11,304 $2.73 Million
Q4 2021

Feb 02, 2022

BUY
$198.88 - $227.6 $215,387 - $246,490
1,083 Added 16.04%
7,836 $1.76 Million
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $708,132 - $829,663
3,336 Added 97.63%
6,753 $1.44 Million
Q2 2021

Aug 09, 2021

SELL
$233.58 - $259.14 $39,241 - $43,535
-168 Reduced 4.69%
3,417 $780,000
Q1 2021

May 17, 2021

BUY
$221.91 - $258.6 $795,547 - $927,081
3,585 New
3,585 $904,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Gries Financial LLC Portfolio

Follow Gries Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gries Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gries Financial LLC with notifications on news.